Marothi Letsoalo

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study”.

Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study

The Lancet HIV(2025)10.1016/s2352-3018(24)00312-6

N/A

0.315DataRank · unranked

5 citations

Hylke Waalewijn, Kogieleum Naidoo, Marothi Letsoalo, Gabriela Cromhout, Leora Sewnarain +8 more

Fixed-dose combination bictegravir–emtricitabine–tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial

The Lancet HIV(2025)10.1016/s2352-3018(25)00200-0

N/A

0.165DataRank · unranked

2 citations

Kogieleum Naidoo, Marothi Letsoalo, Roeland E. Wasmann, Gillian Dorse, Rubeshan Perumal +33 more

Performance of Softcup® menstrual cup and vulvovaginal swab samples for detection and quantification of genital cytokines

Journal of Immunological Methods(2024)10.1016/j.jim.2024.113656

N/A

0DataRank · unranked

2 citations

Gugulethu Mzobe, Marothi Letsoalo, Asavela Olona Kama, Andile Mtshali, Stanley Nzuzo Magini +9 more

Population pharmacokinetics of weight-based compared with fixed dosing of CAP256V2LS, a broadly neutralizing antibody for HIV prevention in women

Journal of Antimicrobial Chemotherapy(2025)10.1093/jac/dkaf181

N/A

0DataRank · unranked

1 citations

Martin Béliveau, Roberto Heredia‐Ortiz, Farzana Osman, Marothi Letsoalo, Nigel Garrett +13 more

Pharmacokinetics of Twice-daily Tenofovir Alafenamide in Adults With HIV-associated Tuberculosis on Bictegravir/Emtricitabine/Tenofovir Alafenamide and Rifampicin

Clinical Infectious Diseases(2025)10.1093/cid/ciaf732

N/A

0DataRank · unranked

0 citations

Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo, Kogieleum Naidoo, R Perumal, James F Rooney +32 more